Ribavirin for patients with Crimean–Congo haemorrhagic fever: a systematic review and meta-analysis | Zendy

Sibel Aşçıoğlu | Zendy; Hakan Leblebicioğlu | Zendy; Haluk Vahaboğlu | Zendy; K. Arnold Chan | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Ribavirin for patients with Crimean–Congo haemorrhagic fever: a systematic review and meta-analysis

Author(s) -

Sibel Aşçıoğlu,

Hakan Leblebicioğlu,

Haluk Vahaboğlu,

K. Arnold Chan

Publication year - 2011

Publication title -

journal of antimicrobial chemotherapy

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 2.124

H-Index - 194

eISSN - 1460-2091

pISSN - 0305-7453

DOI - 10.1093/jac/dkr136

Subject(s) - ribavirin , medicine , observational study , meta analysis , randomized controlled trial , relative risk , clinical endpoint , confidence interval , adverse effect , intensive care medicine , virology , virus , hepatitis c virus

Crimean-Congo haemorrhagic fever (CCHF) is a potentially fatal tick-borne infection. The virus is widely distributed around the world and reports of sporadic cases and outbreaks have recently increased significantly. Some authors have proposed that ribavirin improves survival in CCHF and this view appears to be widely accepted.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research